Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung CancerByDave Nellesen, PhD,Katerine Dea, MSc,Annie Guerin, MSc,Kenneth W. Culver, MD,Alex Mutebi, PhD,Anand Dalal, MBA, BSPharmFebruary 19th 2018This review assesses the current molecular testing landscape for non–small-cell lung cancer in the United States.
eAppendixByDave Nellesen, PhD,Katerine Dea, MSc,Annie Guerin, MSc,Kenneth W. Culver, MD,Alex Mutebi, PhD,Anand Dalal, MBA, BSPharmFebruary 17th 2018